SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: CY Chen who wrote (1785)4/29/1998 5:25:00 PM
From: Mazman  Respond to of 9523
 
CY Chen,

I would think that insurance companies would more tightly limit reimbursement for baldness medications than for anti-depressive drugs, since the former is largely cosmetic and the latter more life altering and debilitating.

As to what we can do? You might want to call your insurance company and find out what your own coverage includes. If not happy, go shopping for a new policy.

Just my two cents.

Regards,

Mazman



To: CY Chen who wrote (1785)4/29/1998 10:13:00 PM
From: Marshall Teitelbaum  Read Replies (1) | Respond to of 9523
 
CY,

These are already issues. The majority of insurance companies already have their own formularies, and their people apparently do better financially if they can keep patients on formulary a greater % of the time...pretty scary if this is true as I have heard. Nevertheless, they often have a few antidepressants on the formulary, or a few of any family of medications, and if you choose one not on their magic list, get ready to do extra paper work or sit on the phone(the physician), and maybe get the approval, or else the patient has to pay. Of course, if you go along with insurance company and their is a problem, the dr. will be the one sued, not the insurance company. Makes it hard for a dr. to please patients these days.

I still think that PFE has even greater potential for their intranasal insulin than even Viagra has, although it is some time off.

Regards,

Marshall